(Welcoming speech by Dr. Xiao Chuanxing, Chairman of TreatGut Pharmaceutical Group)

      Dr. Xiao Chuanxing, Chairman of TreatGut Pharmaceutical Group, first delivered a speech. He expressed his warm welcome and heartfelt thanks to all the leaders, academicians, experts and guests. Chairman Xiao Chuanxing reviewed the development history of TreatGut Pharmaceutical Group. Since its establishment in 2016, the company has always focused on human microecological transplantation and is committed to building a full industry chain enterprise integrating R&D, intelligent manufacturing, sales and service. Today, the official opening of the R&D headquarters marks that TreatGut Pharmaceutical Group's R&D capabilities and innovation level in the field of microecological medicine will reach a new level. He said that the group will take this opportunity to increase investment in research and development, continue to innovate, and make greater contributions to the development of the global microecological pharmaceutical industry.

(Speech by Mr. Wang Nai, Member of the Standing Committee of the Baoshan District Committee and Deputy District Governor of Shanghai)

Wang Nai, member of the Standing Committee of the Shanghai Baoshan District Committee and deputy district mayor, delivered a speech. Deputy District Mayor Wang Nai said that Baoshan District has always been committed to creating a good innovation and entrepreneurship environment and actively promoting the development of emerging industries such as biomedicine. As an industry leader, TreatGut Pharmaceutical Group has made remarkable achievements in the field of microecological medicine. The opening of the R&D headquarters will inject new vitality into the biopharmaceutical industry in Baoshan District. The district government will continue to provide a full range of services and support to help enterprises become bigger and stronger, and jointly promote the innovative development of the microecological pharmaceutical industry.

(Speech by Wang Qi, master of traditional Chinese medicine and academician of the Chinese Academy of Engineering)

      Academician Wang Qi said that the research on intestinal microecology carried out by TreatGut Pharmaceutical Group, the construction of the bacterial flora library and the establishment of the microbial pharmaceutical industry have greatly promoted the development of the microecological pharmaceutical industry.

(Father of the world's microecology, foreign academician of the Chinese Academy of Sciences,

James Tiedje, academician of the National Academy of Sciences, delivers an online speech)

      Academician James Tiedje said that intestinal microorganisms are closely related to the occurrence and development of diseases. He spoke highly of TreatGut Pharmaceutical Group's research and practice in the field of microecological medicine. Congratulations on the opening of the R&D headquarters of TreatGut Pharmaceutical Group and wish this micro-ecological pharmaceutical industry innovation conference a complete success.

TreatGut Pharmaceutical Group R&D headquarters opens

(The R&D headquarters of TreatGut Pharmaceutical Group was officially opened)

      The R&D headquarters of TreatGut Pharmaceutical Group has been officially opened. With a new starting point and a new journey, TreatGut Pharmaceutical Group will continue to use Shanghai as its strategic core and strive to build a world-class R&D and innovation base. Actively carry out in-depth cooperation with the country's top scientific research institutions, introduce cutting-edge technologies and innovative concepts, and continue to enhance the core competitiveness of TreatGut Pharmaceutical Group. TreatGut Pharmaceutical Group will move forward with more determination towards its grand goal of becoming the world's leading pharmaceutical company!

(Launching ceremony of precision medicine (microbiota transplantation) innovation consortium)

Under the guidance of Shanghai Baoshan District Science and Technology Commission, TreatGut Pharmaceutical Group established a precision medicine (microbiota transplantation) innovation consortium in partnership with the Institute of Urban Environment of the Chinese Academy of Sciences, the Institute of Microbiology Technology of Shandong University, the School of Public Health of Xiamen University, Wuhan Zhenxi Medical Laboratory Co., Ltd., China Pharmaceutical University, IFF and other companies.

The precision medicine (microbiota transplantation) innovation consortium will give full play to its advantages in microbiota medicine research and development, production, and marketing, promote the clinical application and transformation of the microbiota medical industry, and assist the industrial development of the consortium. The official launch of the precision medicine (microbiota transplantation) innovation consortium marks that our research and application in the field of microecology has entered a new stage.

      TreatGut Pharmaceutical Group has signed cooperation agreements with universities and scientific research institutions such as the Institute of Microbial Technology of Shandong University, the School of Public Health of Xiamen University, the School of Basic Medicine of Central South University, the School of Medicine of the University of Electronic Science and Technology of China, Shenyang City College, the Third Institute of Oceanography of the Ministry of Natural Resources, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, the Institute of Urban Environment of the Chinese Academy of Sciences, Shanghai Yangsi Hospital, and Oriental Hospital Affiliated to Tongji University.

Through school-enterprise cooperation, both parties will carry out in-depth cooperation in clinical application, scientific research, achievement transformation, platform construction and talent training. Promote micro-ecological medical technology innovation and service model innovation in an all-round way.

Master of Traditional Chinese Medicine, Academician of Chinese Academy of EngineeringWang Qi

"Research on Intestinal Microbiota, Intestinal Polyps and Intervention with Traditional Chinese Medicine"

      Academician Wang Qi shared: "Research on gut microbiota, Intestinal Polyps and Intervention with Traditional Chinese Medicine". He pointed out that there is a clear correlation between gut microbiota and the occurrence and development of intestinal polyps. Intervention and regulation of gut microbiota from the perspective of traditional Chinese medicine can prevent the occurrence of intestinal polyps. Academician Wang Qi said that TreatGut will carry out relevant research on intestinal messages to provide more precise intervention plans for patients with intestinal polyps.

Academician of the Chinese Academy of Engineering and nutritionistYin Yulong

"Gut Microbial Quorum Sensing Screening of Alternative Antibiotic Products"

      Academician Yin Yulong shared: "Intestinal Microbial Quorum Sensing Screening of Alternative Antibiotic Products". He elaborated on the types of intestinal microbial quorum sensing and the idea of screening alternative antibacterial products based on intestinal microbial quorum sensing. Provide new ideas for the future development of intestinal microorganisms.

(Intestinal news multi-center clinical research launching ceremony)

The multi-center clinical research project on intestinal news led by Wang Qi, a master of traditional Chinese medicine and an academician of the Chinese Academy of Engineering, was officially launched. This research will focus on the microecological treatment of intestinal diseases and provide a more solid scientific basis for the clinical application of the microecological pharmaceutical industry.

(Launching Ceremony of East China Microbiome Library)

      China Microbiota Bank Alliance was initiated and established by TreatGut Pharmaceutical Group. As a key force in the field of microecology in my country, its core mission is to protect the rich diversity of gut microbiota of healthy people in China, to ensure the absolute security of intestinal microecological genetic data, and to contribute to the protection of precious human genetic resources, which is of far-reaching and significant significance.

       The establishment of the East China Microbiome Library is an important infrastructure construction project in the development of the microecological pharmaceutical industry. It will collect and preserve rich and diverse gut microbiota samples in East China, establish a complete flora resource database, and carry out related flora analysis and research work. It provides rich flora resources for microecological medicine research, helps to deeply understand the intestinal microecological characteristics of different groups of people, and provides important basic data and research platform for microecological drug research and development, personalized medicine, etc.

(TreatGut Pharmaceutical Group signed a contract with MGI)

      TreatGut Pharmaceutical Group signed a cooperation project with MGI for gut microbiota genetic testing. TreatGut will promote gut microbiota genetic testing from the laboratory to the bedside, provide customers with more accurate diagnostic evidence, develop more personalized treatment plans for patients, and achieve seamless connection between scientific research results and clinical applications.

(TreatGut Pharmaceutical Group signs contract with IFF)

      TreatGut Pharmaceutical Group and IFF have reached a strategic cooperation agreement on gut microbiota. By sharing technology, resources and market channels, the two parties will jointly develop and promote higher-quality gut microbiota-related products to meet the market's growing health needs, promote the prosperity and development of the gut microbiota product market, and protect the health of consumers.

TreatGut Medical Laboratory released the third-generation gut microbiota gene detection product, which uses the combined technology of 16S+tNGS to expand the detection scope, personalize microbiome analysis, and fully open the era of accurate detection 3.0.

TreatGut Health Division launches microbiota transplantation, a high-end brand for health industry, academia and research use - Qiwu Yisheng, which starts from the diversity of gut microbiota and increases the diversity of human flora! Optimize the diversity structure of bacterial flora to improve human ecological capabilities and achieve health.

TreatGut Health Division launched the national micro-ecological age reduction and anti-aging leading brand - EGS, which focuses on micro-ecology and anti-aging, explores the truth of internal and external skin care from a microscopic perspective, and is a comprehensive anti-aging and beauty solution that is more suitable for Chinese people.

TreatGut Medical Division released an integrated product plan for metabolic disease microecology. Focusing on metabolic diseases, it starts a new journey of microecological therapy for metabolic diseases through precise traceability, precise transplantation, and precise nutrition.

The TreatGut Health Division released the regenerative medicine project - CPP, which is based on the technology accumulation of TreatGut Pharmaceutical Group's more than ten years of microbiota transplantation application. It is specially tailored for the cell industry. It focuses on six major segments: intestinal anti-aging, vascular anti-aging, emotional anti-aging, male and female anti-aging, and immune balance. It specializes in serving the cell industry.

TreatGut Pharmaceutical Group presented a series of innovative and market-competitive microecological products and projects at the press conference, covering multiple fields of microecological health. They will meet the diverse needs of the market with excellent quality and unique advantages, and contribute greatly to human health.

      The opening of TreatGut Pharmaceutical Group's R&D headquarters and the successful holding of the 2025 Microecological Pharmaceutical Industry Innovation Conference not only demonstrated TreatGut Pharmaceutical Group's strong strength and innovative achievements in the field of microecological medicine, but also established a platform for exchange and cooperation for the development of the microecological pharmaceutical industry, which is of great significance in promoting the innovative development of my country's microecological pharmaceutical industry. It is believed that with the joint efforts of governments, enterprises, universities and scientific research institutions, the microecological pharmaceutical industry will usher in a better future.